Background: Advanced colorectal cancer (CRC) is associated with significant morbidity, which, combined with the adverse effects of cancer treatment, can further impair patient quality of life. The primary objective was to evaluate the impact of Ocoxin oral solution (OOS) in combination with oxaliplatin-based chemotherapy on quality of life. Methods: Forty patients participated in an exploratory, prospective, multicentre clinical trial at the “Hermanos Ameijeiras” University Hospital and the National Institute of Oncology in Havana, Cuba. Quality of life was measured using the EORTC QLQ-C30 and EORTC QLQ-C29 questionnaires. Toxicity was assessed using the NCI-CTC-AE classification, version 4.0. Results: Scores remained stable over time for global quality of life and functional scale criteria, while, regarding symptoms, a reduction in pain perception and loss of appetite was observed at three months. The number and severity of adverse events were lower (4.2% grade 3 - 4) than those reported with this type of chemotherapy. No adverse events (AEs) related to OOS were recorded. Biochemical and nutritional parameters remained stable during treatment. Conclusions: This clinical study is the first report on the use of OOS in patients with metastatic colon cancer, maintaining optimal quality of life and reducing the intensity of chemotherapy toxicity.
KeywordsEORTC QLQ-C30EORTC QLQ-C29OcoxinChemotherapyColorectal CancerQuality of Life
Siegel, R.L., Wagle, N.S., Cercek, A., Smith, R.A. and Jemal, A. (2023) Colorectal Cancer Statistics, 2023. CA : A Cancer Journal for Clinicians , 73, 233-254. https://doi.org/10.3322/caac.21772
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA : A Cancer Journal for Clinicians , 74, 229-263. https://doi.org/10.3322/caac.21834
Sonbol, M.B., Mountjoy, L.J., Firwana, B., Liu, A.J., Almader-Douglas, D., Mody, K., et al. (2020) The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. JAMA Oncology , 6, e194489. https://doi.org/10.1001/jamaoncol.2019.4489
Lima Pérez, M., Galán Alvarez, Y.H., Soriano García, J.L., Iglesias Ventura, Y. and Medina Pérez, V.M. (2021) Incidencia y mortalidad en Cuba por cáncer del sistema digestivo, 2015-2017. Revista Cubana de Oncología , 19, e142. https://revoncologia.sld.cu/index.php/onc/article/view/142
Arnold, M., Abnet, C.C., Neale, R.E., Vignat, J., Giovannucci, E.L., McGlynn, K.A., et al. (2020) Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastr oenterology , 159, 335-349.e15. https://doi.org/10.1053/j.gastro.2020.02.068
Vogel, A., Hofheinz, R.D., Kubicka, S. and Arnold, D. (2017) Treatment Decisions in Metastatic Colorectal Cancer—Beyond First and Second Line Combination Therapies. Cancer Treatment Reviews , 59, 54-60. https://doi.org/10.1016/j.ctrv.2017.04.007
Braun, D.P., Gupta, D., Grutsch, J.F. and Staren, E.D. (2011) Can Changes in Health Related Quality of Life Scores Predict Survival in Stages III and IV Colorectal Cancer? Health and Quality of Life Outcomes , 9, Article No. 62. https://doi.org/10.1186/1477-7525-9-62
Lombardi, P., Marandino, L., De Luca, E., Zichi, C., Reale, M.L., Pignataro, D., et al. (2020) Quality of Life Assessment and Reporting in Colorectal Cancer: A Systematic Review of Phase III Trials Published between 2012 and 2018. Critical Reviews in Oncology / Hematology , 146, Article ID: 102877. https://doi.org/10.1016/j.critrevonc.2020.102877
Bonnetain, F., Borg, C., Adams, R.R., Ajani, J.A., Benson, A., Bleiberg, H., et al. (2017) How Health-Related Quality of Life Assessment Should Be Used in Advanced Colorectal Cancer Clinical Trials. Annals of Oncology , 28, 2077-2085. https://doi.org/10.1093/annonc/mdx191
Pandiella-Alonso, A., Díaz-Rodríguez, E. and Sanz, E. (2020) Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review. Nutrie nts , 12, Article 2661. https://doi.org/10.3390/nu12092661
Pérez-Peña, J., Díaz-Rodríguez, E., Sanz, E. and Pandiella, A. (2019) Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin. Nutrients , 11, Article 1068. https://doi.org/10.3390/nu11051068
García‐Perdomo, H.A., Gómez‐Ospina, J.C. and Reis, L.O. (2021) Immunonutrition Hope? Oral Nutritional Supplement on Cancer Treatment. International Journal of Clinical Practice , 75, e14625. https://doi.org/10.1111/ijcp.14625
Cocks, K., King, M.T., Velikova, G., de Castro, G., Martyn St-James, M., Fayers, P.M., et al. (2012) Evidence-Based Guidelines for Interpreting Change Scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer , 48, 1713-1721. https://doi.org/10.1016/j.ejca.2012.02.059
Meyerhardt, J.A. and Mayer, R.J. (2005) Systemic Therapy for Colorectal Cancer. New England Journal of Medicine , 352, 476-487. https://doi.org/10.1056/nejmra040958
Hoff, P.M., Ansari, R., Batist, G., Cox, J., Kocha, W., Kuperminc, M., et al. (2001) Comparison of Oral Capecitabine versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients with Metastatic Colorectal Cancer: Results of a Randomized Phase III Study. Journal of Clinical Oncology , 19, 2282-2292. https://doi.org/10.1200/jco.2001.19.8.2282
Grothey, A., Sargent, D., Goldberg, R.M. and Schmoll, H. (2004) Survival of Patients with Advanced Colorectal Cancer Improves with the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment. Journal of Clinical Oncology , 22, 1209-1214. https://doi.org/10.1200/jco.2004.11.037
Leowattana, W., Leowattana, P. and Leowattana, T. (2023) Systemic Treatment for Metastatic Colorectal Cancer. World Journal of Gastroenterology , 29, 1569-1588. https://doi.org/10.3748/wjg.v29.i10.1569
Shin, A.E., Giancotti, F.G. and Rustgi, A.K. (2023) Metastatic Colorectal Cancer: Mechanisms and Emerging Therapeutics. Trends in Pharmacological Sciences , 44, 222-236. https://doi.org/10.1016/j.tips.2023.01.003
Ciardiello, D. and Petrillo, A. (2024) Editorial: Optimizing the First-Line Treatment for Metastatic Colorectal Cancer. Frontiers in Oncology , 14, Article 1366383. https://doi.org/10.3389/fonc.2024.1366383
Ducreux, M., Bennouna, J., Hebbar, M., Ychou, M., Lledo, G., Conroy, T., et al. (2010) Capecitabine Plus Oxaliplatin (XELOX) versus 5-Fluorouracil/Leucovorin plus Oxaliplatin (FOLFOX‐6) as First‐line Treatment for Metastatic Colorectal Cancer. International Journal of Cancer , 128, 682-690. https://doi.org/10.1002/ijc.25369
Silva, N.M., Santos, M.A.D., Rosado, S.R., Galvão, C.M. and Sonobe, H.M. (2017) Psychological Aspects of Patients with Intestinal Stoma: Integrative Review. Revista Latino - Americana de Enfermagem , 25, e2950. https://doi.org/10.1590/1518-8345.2231.2950
Li, J., Yuan, Y., Yang, F., Wang, Y., Zhu, X., Wang, Z., et al. (2019) Expert Consensus on Multidisciplinary Therapy of Colorectal Cancer with Lung Metastases (2019 Edition). Journal of Hematology & Oncology , 12, Article No. 16. https://doi.org/10.1186/s13045-019-0702-0
Prasanna, T., Karapetis, C.S., Roder, D., Tie, J., Padbury, R., Price, T., et al. (2018) The Survival Outcome of Patients with Metastatic Colorectal Cancer Based on the Site of Metastases and the Impact of Molecular Markers and Site of Primary Cancer on Metastatic Pattern. Acta Oncologica , 57, 1438-1444. https://doi.org/10.1080/0284186x.2018.1487581
Nordholm-Carstensen, A., Krarup, P., Jorgensen, L.N., Wille-Jørgensen, P.A. and Harling, H. (2014) Occurrence and Survival of Synchronous Pulmonary Metastases in Colorectal Cancer: A Nationwide Cohort Study. European Journal of Cancer , 50, 447-456. https://doi.org/10.1016/j.ejca.2013.10.009
Adeleke, A., Adebayo, A.S., Agbaje, K., Olajubutu, O. and Adesina, S.K. (2025) Colorectal Cancer: Therapeutic Approaches and Their Complications. Biomedicines , 13, Article 1646. https://doi.org/10.3390/biomedicines13071646
Ye, J., Hu, Y., Chen, X., Chang, C. and Li, K. (2023) Comparative Effects of Different Nutritional Supplements on Inflammation, Nutritional Status, and Clinical Outcomes in Colorectal Cancer Patients: A Systematic Review and Network Meta-Analysis. Nutrients , 15, Article 2772. https://doi.org/10.3390/nu15122772
Moore, M.M., Chua, W., Charles, K.A. and Clarke, S.J. (2010) Inflammation and Cancer: Causes and Consequences. Clinical Pharmacology & Therapeutics , 87, 504-508. https://doi.org/10.1038/clpt.2009.254
Burden, S.T., Hill, J., Shaffer, J.L. and Todd, C. (2010) Nutritional Status of Preoperative Colorectal Cancer Patients. Journal of Human Nutrition and Dietetics , 23, 402-407. https://doi.org/10.1111/j.1365-277x.2010.01070.x
Janakiram, N.B., Mohammed, A., Madka, V., Kumar, G. and Rao, C.V. (2016) Prevention and Treatment of Cancers by Immune Modulating Nutrients. Molecular Nutrition & Food Research , 60, 1275-1294. https://doi.org/10.1002/mnfr.201500884
Kim, C. and Kim, B. (2018) Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review. Nutrients , 10, Article 1021. https://doi.org/10.3390/nu10081021
Maiuolo, J., Gliozzi, M., Carresi, C., Musolino, V., Oppedisano, F., Scarano, F., et al. (2021) Nutraceuticals and Cancer: Potential for Natural Polyphenols. Nutrients , 13, Article 3834. https://doi.org/10.3390/nu13113834
Márquez, J., Mena, J., Hernandez-Unzueta, I., Benedicto, A., Sanz, E., Arteta, B., et al. (2015) Ocoxin® Oral Solution Slows down Tumor Growth in an Experimental Model of Colorectal Cancer Metastasis to the Liver in Balb/c Mice. Oncology Reports , 35, 1265-1272. https://doi.org/10.3892/or.2015.4486
Hernandez-Unzueta, I., Benedicto, A., Olaso, E., Sanz, E., Viera, C., Arteta, B., et al. (2017) Ocoxin Oral Solution® as a Complement to Irinotecan Chemotherapy in the Metastatic Progression of Colorectal Cancer to the Liver. Oncology Letters , 13, 4002-4012. https://doi.org/10.3892/ol.2017.6016
Renfro, L.A., Loupakis, F., Adams, R.A., Seymour, M.T., Heinemann, V., Schmoll, H., et al. (2016) Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients from First-Line Clinical Trials in the ARCAD Database. Journal of Clinical Oncology , 34, 144-150. https://doi.org/10.1200/jco.2015.61.6441
Cong, Z., Wang, D. and Cao, Y. (2018) The Relationship between Body Mass Index Changes during Chemotherapy and Prognosis of Patients with Advanced Colorectal Cancer: A Retrospective Cohort Study. Medicine , 97, e10843. https://doi.org/10.1097/md.0000000000010843
Innominato, P.F., Giacchetti, S., Moreau, T., Bjarnason, G.A., Smaaland, R., Focan, C., et al. (2013) Fatigue and Weight Loss Predict Survival on Circadian Chemotherapy for Metastatic Colorectal Cancer. Cancer , 119, 2564-2573. https://doi.org/10.1002/cncr.28072
Prejac, J., Kekez, D., Belev, B., Prejac, M. and Pleština, S. (2021) Frequency of Body Weight Loss Is an Independent Prognostic Factor of First-Line Treatment Outcomes in Metastatic Colorectal Cancer. Nutrition and Cancer , 74, 520-526. https://doi.org/10.1080/01635581.2021.1900300
Bhat, A.A., Nisar, S., Singh, M., Ashraf, B., Masoodi, T., Prasad, C.P., et al. (2022) Cytokine-and Chemokine-Induced Inflammatory Colorectal Tumor Microenvironment: Emerging Avenue for Targeted Therapy. Cancer Communications , 42, 689-715. https://doi.org/10.1002/cac2.12295
Formica, V., Luccchetti, J., Cunningham, D., Smyth, E.C., Ferroni, P., Nardecchia, A., et al. (2014) Systemic Inflammation, as Measured by the Neutrophil/Lymphocyte Ratio, May Have Differential Prognostic Impact before and during Treatment with Fluorouracil, Irinotecan and Bevacizumab in Metastatic Colorectal Cancer Patients. Medical Oncology , 31, Article No. 166. https://doi.org/10.1007/s12032-014-0166-6
Shen, X., Xiang, M., Tang, J., Xiong, G., Zhang, K., Xia, T., et al. (2024) Evaluation of Peripheral Blood Inflammation Indexes as Prognostic Markers for Colorectal Cancer Metastasis. Scientific Reports , 14, Article No. 20489. https://doi.org/10.1038/s41598-024-68150-y
Hernandez-Unzueta, I., Benedicto, A., Romayor, I., Herrero, A., Sanz, E., Arteta, B., et al. (2019) Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas , 48, 555-567. https://doi.org/10.1097/mpa.0000000000001277
Lima-Pérez, M., Soriano-García, J.L., González-Meisozo, M., Soriano-Lorenzo, J.L., Fleites-Calvo, V., Morales-Morgado, D., et al. (2024) Nutritional Supplement Ocoxin ® Combined with Gemcitabine-Based Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma. Open Journal of Gastroenterology , 14, 267-287. https://doi.org/10.4236/ojgas.2024.148030
Wang, J., Li, J., Wei, S., Xu, J., Jiang, X. and Yang, L. (2021) The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis. Gastroenterology Research and Practice , 2021, Article ID: 9699499. https://doi.org/10.1155/2021/9699499
Plantureux, L., Mège, D., Crescence, L., Carminita, E., Robert, S., Cointe, S., et al. (2020) The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis. Cancer Research , 80, 291-303. https://doi.org/10.1158/0008-5472.can-19-1181
Stojanovska, V., Prakash, M., McQuade, R., Fraser, S., Apostolopoulos, V., Sakkal, S., et al. (2019) Oxaliplatin Treatment Alters Systemic Immune Responses. BioMed Resear c h International , 2019, Article ID: 4650695. https://doi.org/10.1155/2019/4650695
Benedicto, A., Sanz, E. and Márquez, J. (2021) Ocoxin as a Complement to First Line Treatments in Cancer. International Journal of Medical Sciences , 18, 835-845. https://doi.org/10.7150/ijms.50122
McGarrah, P., Hubbard, J., Novotny, P.J., Branda, M.E., Sargent, D.S., Morton, R.F., et al. (2023) Baseline Quality of Life Is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer. Cancer Control , 30, 1-10. https://doi.org/10.1177/10732748231185047
Raimondi, A., Di Maio, M., Morano, F., Corallo, S., Lonardi, S., Antoniotti, C., et al. (2020) Health-Related Quality of Life in Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Panitumumab-Based First-Line Treatment Strategy: A Pre-Specified Secondary Analysis of the Valentino Study. European Journal of Cancer , 135, 230-239. https://doi.org/10.1016/j.ejca.2020.04.048
Miguel, K.L., Ávila, D.R.M., Pérez, L.Á., Rabasa, G.M., Lambert, A.L., Noa, R.E., et al. (2022) The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy. Journal of Cancer Therapy , 13, 561-584. https://doi.org/10.4236/jct.2022.139050
Fundora Ramos, M., Boulet Maden, L., Oriol Casanova, F., Hernández Cruz, F., Salgado Reyes, C., Hernandez Gato, A., et al. (2020) Oncoxin-Viusid ® May Improve Quality of Life and Survival in Patients with Hormonerefractory Prostate Cancer Undergoing Onco-Specific Treatments. Molecular and Clinical Oncology , 14, Article No. 5. https://doi.org/10.3892/mco.2020.2167
Lorente, R.R., Durán, D.H., Viamontes, J.G., Anta, J.L., Reyes, R.O. and Navares, E.S. (2020) Efficacy of Oncoxin-Viusid on the Reduction of Adverse Reactions to Chemotherapy and Radiotherapy in Patients Diagnosed with Cervical Cancer and Endometrial Adenocarcinoma. Journal of Cancer Therapy , 11, 276-295. https://doi.org/10.4236/jct.2020.115023
Ruiz de Galarreta, M., Arriazu, E., Pérez de Obanos, M.P., Ansorena, E. and Iraburu, M.J. (2022) Antifibrogenic and Apoptotic Effects of Ocoxin in Cultured Rat Hepatic Stellate Cells. Journal of Physiology and Biochemistry , 79, 881-890. https://doi.org/10.1007/s13105-022-00878-5
Vilar Gomez, E., Rodriguez de Miranda, A., Gra Oramas, B., Arus Soler, E., Llanio Navarro, R., Calzadilla Bertot, L., et al. (2009) Clinical Trial: A Nutritional Supplement Viusid, in Combination with Diet and Exercise, in Patients with Nonalcoholic Fatty Liver Disease. Alimentary Pharmacology & Therapeutics , 30, 999-1009. https://doi.org/10.1111/j.1365-2036.2009.04122.x
Pérez-Burillo, S., Navajas-Porras, B., López-Maldonado, A., Hinojosa-Nogueira, D., Pastoriza, S. and Rufián-Henares, J.Á. (2021) Green Tea and Its Relation to Human Gut Microbiome. Molecules , 26, Article 3907. https://doi.org/10.3390/molecules26133907
Zhang, Y., Sheng, Z., Xiao, J., Li, Y., Huang, J., Jia, J., et al. (2023) Advances in the Roles of Glycyrrhizic Acid in Cancer Therapy. Frontiers in Pharmacology , 14, Article 1265172. https://doi.org/10.3389/fphar.2023.1265172
Bak, Y., Lampe, J.W. and Sung, M. (2014) Effects of Dietary Supplementation of Glucosamine Sulfate on Intestinal Inflammation in a Mouse Model of Experimental Colitis. Journal of Gastroenterology and Hepatology , 29, 957-963. https://doi.org/10.1111/jgh.12485
Wan, Y. and Zhang, B. (2022) The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases. Biomolecules , 12, Article 900. https://doi.org/10.3390/biom12070900
Hernandez-Unzueta, I., Telleria-Gonzalez, U., Aransay, A.M., Martin Rodriguez, J.E., Sanz, E. and Márquez, J. (2025) Unravelling the Antitumor Mechanism of Ocoxin through Cancer Cell Genomics. Frontiers in Pharmacology , 16, Article 1540217. https://doi.org/10.3389/fphar.2025.1540217
Buck, I., Morceau, F., Grigorakaki, C., Dicato, M. and Diederich, M. (2009) Linking Anemia to Inflammation and Cancer: The Crucial Role of TNF α . Biochemical Pharmacology , 77, 1572-1579. https://doi.org/10.1016/j.bcp.2008.12.018
Chu, T., Hu, S., Qi, J., Li, X., Zhang, X., Tang, Y., et al. (2022) Bifunctional Effect of the Inflammatory Cytokine Tumor Necrosis Factor Α on Megakaryopoiesis and Platelet Production. Journal of Thrombosis and Haemostasis , 20, 2998-3010. https://doi.org/10.1111/jth.15891
Wang, R.Y., Lin, X.L., Xiang, S.T., Sun, Q.H. and Ding, X.H. (2022) Risk Factors for Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. European Review for Medical and Pharmacological Sciences , 26, 4028-4043. https://doi.org/10.26355/eurrev_202206_28973
Yang, Y., Zhao, B., Gao, X., Sun, J., Ye, J., Li, J., et al. (2021) Targeting Strategies for Oxaliplatin-Induced Peripheral Neuropathy: Clinical Syndrome, Molecular Basis, and Drug Development. Journal of Experimental & Clinical Cancer Research , 40, Article No. 331. https://doi.org/10.1186/s13046-021-02141-z
Mine, K., Kawashiri, T., Mori, K., Mori, Y., Ishida, H., Kudamatsu, H., et al. (2025) Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin-Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study. Pharmacotherapy : The Journal of Human Pharmacology and Drug Therapy , 45, 435-447. https://doi.org/10.1002/phar.70028
Moretto, R., Corallo, S., Belfiore, A., Rossini, D., Boccaccino, A., Lonardi, S., et al. (2020) Prognostic Impact of Immune-Microenvironment in Colorectal Liver Metastases Resected after Triplets Plus a Biologic Agent: A Pooled Analysis of Five Prospective Trials. European Journal of Cancer , 135, 78-88. https://doi.org/10.1016/j.ejca.2020.04.045
Rier, H.N., Jager, A., Sleijfer, S., Maier, A.B. and Levin, M. (2016) The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. The Oncologist , 21, 1396-1409. https://doi.org/10.1634/theoncologist.2016-0066